Prot #LX4211.1-314-HCM: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic obstructive And non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)

Project: Research project

Project Details

StatusActive
Effective start/end date12/20/2412/20/27

Funding

  • Fortrea, Inc. (Prot #LX4211.1-314-HCM // Prot #LX4211.1-314-HCM)
  • Lexicon Pharmaceuticals, Inc. (Prot #LX4211.1-314-HCM // Prot #LX4211.1-314-HCM)